At a glance
ClinicalIndex Comparison RecordN/ACompleted· 25 enrolled
Drug / intervention
Venus Vivadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Safety and Performance of Fractional Radiofrequency for the Treatment and Reduction of Facial Wrinkles
In Brief
A clinical study evaluating Venus Viva for Rhytides and Wrinkle. Completed, enrolled 25 participants across 1 site.
Detailed Summary
Prospective, single centre, evaluator-blind study of the safety and performance of fractional radiofrequency (RF) for the treatment and reduction of facial wrinkles.
Study Details
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedDec 2018
Enrollment StartMar 2019
Primary CompletionJun 2021
TodayJul 2026
First PostedDec 14, 2018
Enrollment StartMar 8, 2019
Primary CompletionJun 18, 2021
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.5 years ago
Interventions
Venus Vivadevice
The Venus Viva™ is a non-invasive medical aesthetic device, intended for use in dermatologic and general surgical procedures, requiring ablation and resurfacing of the skin, using the Viva applicator.